JA
Jack Allen Baird Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Vor Biopharma
VOR
$251M
| $2.01 | $1 |
50%
downside
| Neutral |
27 Jun ‘25
2 months ago |
|
2
Fate Therapeutics
FATE
$111M
| $0.9799 | $4 |
308%
upside
| Neutral |
14 May ‘25
3 months ago |
|
3
Allogene Therapeutics
ALLO
$253M
| $1.14 | $9 |
689%
upside
| Outperform |
14 May ‘25
3 months ago |
|
4
Carisma Therapeutics
CARM
$16.6M
| $0.4139 | $1 |
142%
upside
| Neutral |
12 Dec ‘24
9 months ago |
|
5
MiNK Therapeutics
INKT
$71.6M
| $15.36 | $40 |
160%
upside
| Outperform |
15 Nov ‘24
9 months ago |
|
6
Arcellx
ACLX
$3.94B
| $72.04 | $106 |
47%
upside
| Outperform |
6 Nov ‘24
10 months ago |
|
7
Intellia Therapeutics
NTLA
$1.27B
| $11.88 | $18 |
52%
upside
| Neutral |
25 Oct ‘24
10 months ago |
|
8
Instil Bio
TIL
$174M
| $25.48 | $180 |
606%
upside
| Outperform |
16 Sep ‘24
11 months ago |
|
|
MREO
9
Mereo BioPharma
MREO
$285M
| $1.82 | $8 |
340%
upside
| Outperform |
13 Jun ‘24
1 year ago |
|
10
CRISPR Therapeutics
CRSP
$4.92B
| $53.69 | $52 |
3%
downside
| Neutral |
9 May ‘24
1 year ago |
|
11
Immunocore
IMCR
$1.85B
| $36.59 | $84 |
130%
upside
| Outperform |
31 Oct ‘23
1 year ago |
|
12
Korro Bio
KRRO
$309M
| $36.12 | $25 |
31%
downside
| Neutral |
26 Sep ‘23
1 year ago |
|
13
Taysha Gene Therapies
TSHA
$884M
| $3.28 | $8 |
144%
upside
| Outperform |
15 Aug ‘23
2 years ago |
|
14
Lineage Cell Therapeutics
LCTX
$283M
| $1.27 | $5 |
294%
upside
| Outperform |
2 Nov ‘22
2 years ago |
|
15
Voyager Therapeutics
VYGR
$236M
| $4 | $9 |
125%
upside
| Outperform |
7 Oct ‘21
3 years ago |
|